Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/11/2861476/0/en/SciSparc-to-Acquire-AutoMax.html
https://www.globenewswire.com/news-release/2024/03/27/2853200/0/en/SciSparc-Clearmind-Collaboration-Evolves-with-New-International-Patent-Application-for-Preventing-and-Treating-Depression.html
https://www.globenewswire.com/news-release/2024/03/21/2850254/0/en/SciSparc-MitoCareX-Unveils-Groundbreaking-Discovery-of-Small-Molecule-Structure-in-Anti-Cancer-Research.html
https://www.globenewswire.com/news-release/2024/03/18/2847694/0/en/SciSparc-Granted-Another-Patent-Strengthening-its-Core-Technology-in-Canada.html
https://www.globenewswire.com//news-release/2024/03/14/2846290/0/en/SciSparc-Achieves-Major-Milestone-with-First-Patient-Dosed-in-Autism-Spectrum-Disorder-Clinical-Trial.html
https://www.globenewswire.com//news-release/2024/03/12/2844506/0/en/SciSparc-MitoCareX-Reveals-Promising-Results-with-Discovery-of-Novel-Anti-Cancer-Small-Molecule-Structure.html
https://www.globenewswire.com/news-release/2024/03/08/2843039/0/en/SciSparc-Announces-Enrollment-of-First-Patient-for-its-Clinical-Trial-for-Children-with-Autism-Spectrum-Disorder.html
https://www.globenewswire.com//news-release/2024/03/06/2841819/0/en/SciSparc-Issued-Canadian-Patent-for-Opioids-Reduction-Use-in-Pain-Management-Technology.html
https://www.globenewswire.com//news-release/2024/02/27/2835919/0/en/SciSparc-Clearmind-Partnership-Yields-Three-New-International-Patent-Applications-for-MDMA-Ibogaine-and-Ketamine-Compounds.html
https://www.globenewswire.com//news-release/2024/02/20/2831697/0/en/SciSparc-and-Clearmind-Continue-to-Strengthen-International-Patent-Portfolio-with-Next-Generation-Classic-Psychedelic-Based-Compounds.html